JP2021521113A5 - - Google Patents
Info
- Publication number
- JP2021521113A5 JP2021521113A5 JP2020554857A JP2020554857A JP2021521113A5 JP 2021521113 A5 JP2021521113 A5 JP 2021521113A5 JP 2020554857 A JP2020554857 A JP 2020554857A JP 2020554857 A JP2020554857 A JP 2020554857A JP 2021521113 A5 JP2021521113 A5 JP 2021521113A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- pharmaceutical composition
- pdsp
- composition according
- pedf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024018183A JP2024054273A (ja) | 2018-04-08 | 2024-02-08 | 腱治癒に対するpedf由来短鎖ペプチドの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862654466P | 2018-04-08 | 2018-04-08 | |
| US62/654,466 | 2018-04-08 | ||
| PCT/US2019/026307 WO2019199661A1 (en) | 2018-04-08 | 2019-04-08 | Application of pedf-derived short peptides in tendon healing |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024018183A Division JP2024054273A (ja) | 2018-04-08 | 2024-02-08 | 腱治癒に対するpedf由来短鎖ペプチドの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021521113A JP2021521113A (ja) | 2021-08-26 |
| JP2021521113A5 true JP2021521113A5 (enExample) | 2022-04-13 |
| JP7481261B2 JP7481261B2 (ja) | 2024-05-10 |
Family
ID=68163751
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020554857A Active JP7481261B2 (ja) | 2018-04-08 | 2019-04-08 | 腱治癒に対するpedf由来短鎖ペプチドの使用 |
| JP2024018183A Pending JP2024054273A (ja) | 2018-04-08 | 2024-02-08 | 腱治癒に対するpedf由来短鎖ペプチドの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024018183A Pending JP2024054273A (ja) | 2018-04-08 | 2024-02-08 | 腱治癒に対するpedf由来短鎖ペプチドの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20210244791A1 (enExample) |
| EP (1) | EP3761959A4 (enExample) |
| JP (2) | JP7481261B2 (enExample) |
| KR (1) | KR20200142521A (enExample) |
| CN (1) | CN113038929A (enExample) |
| AU (2) | AU2019251091A1 (enExample) |
| EA (1) | EA202092368A1 (enExample) |
| IL (1) | IL277689B2 (enExample) |
| TW (1) | TWI902659B (enExample) |
| WO (1) | WO2019199661A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL277689B2 (en) * | 2018-04-08 | 2024-12-01 | Brim Biotechnology Inc | Application of pedf-derived short peptides in tendon healing |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUE035655T2 (en) * | 2005-08-05 | 2018-05-28 | Araim Pharmaceuticals Inc | Tissue protective peptides and their use |
| WO2007095350A2 (en) * | 2006-02-15 | 2007-08-23 | Yale University | Compositions and methods for use of pigment epithelial derived factor (pedf) peptide fragments |
| ES2329636B2 (es) * | 2006-02-17 | 2010-07-26 | Universitat De Valencia, Estudi General (Participa Con El 70%) | Uso del factor pedf para inducir la auto-renovacion de celulas madre. |
| EP2508196B1 (en) * | 2011-03-23 | 2018-09-26 | Mackay Memorial Hospital | Use of PEDF-derived polypeptides for promoting stem cells proliferation and wound healing |
| TWI491616B (zh) * | 2012-08-09 | 2015-07-11 | Mackay Memorial Hospital | 色素上皮衍生因子衍生之多胜肽於促進肌肉或肌腱再生或動脈血管生成之用途 |
| KR101801198B1 (ko) * | 2012-08-09 | 2017-11-24 | 맥케이 메모리얼 호스피탈 | 근육 또는 힘줄 재생 또는 동맥형성을 촉진하기 위해 사용되는 pedf-유도 폴리펩티드의 용도 |
| EA037698B1 (ru) * | 2016-10-07 | 2021-05-12 | Брим Байотекнолоджи, Инк. | Композиции, содержащие короткие пептиды, полученные из pedf, и их применение |
| IL277689B2 (en) * | 2018-04-08 | 2024-12-01 | Brim Biotechnology Inc | Application of pedf-derived short peptides in tendon healing |
-
2019
- 2019-04-08 IL IL277689A patent/IL277689B2/en unknown
- 2019-04-08 JP JP2020554857A patent/JP7481261B2/ja active Active
- 2019-04-08 KR KR1020207031085A patent/KR20200142521A/ko not_active Ceased
- 2019-04-08 CN CN201980038546.7A patent/CN113038929A/zh active Pending
- 2019-04-08 US US17/053,047 patent/US20210244791A1/en not_active Abandoned
- 2019-04-08 EP EP19785477.1A patent/EP3761959A4/en active Pending
- 2019-04-08 AU AU2019251091A patent/AU2019251091A1/en not_active Abandoned
- 2019-04-08 WO PCT/US2019/026307 patent/WO2019199661A1/en not_active Ceased
- 2019-04-08 EA EA202092368A patent/EA202092368A1/ru unknown
- 2019-04-08 TW TW108112195A patent/TWI902659B/zh active
-
2024
- 2024-02-08 JP JP2024018183A patent/JP2024054273A/ja active Pending
-
2025
- 2025-03-04 AU AU2025201569A patent/AU2025201569A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013515057A5 (enExample) | ||
| PE20241305A1 (es) | Analogos de amilina | |
| JP2012176978A5 (enExample) | ||
| JP2013515055A5 (enExample) | ||
| JP2017532343A5 (enExample) | ||
| HRP20140616T1 (hr) | Peptidni analog oksintomodulina | |
| JP2010534684A5 (enExample) | ||
| JP2010519252A5 (enExample) | ||
| JP2017048194A5 (enExample) | ||
| UA100222C2 (uk) | Тканинозахисні пептиди і їх застосування | |
| EA201990885A1 (ru) | Композиции, содержащие короткие пептиды, полученные из pedf, и их применение | |
| JP2007045829A5 (enExample) | ||
| JP2006506942A5 (enExample) | ||
| AR072159A1 (es) | Analogos de glucagon, basados en (peptido insulinotropico dependiente de la glucosa) gip para el tratamiento de trastornos metabolicos y obesidad | |
| RU2016146198A (ru) | Терапевтические dll4-связывающие белки | |
| JP2016509011A5 (enExample) | ||
| EP3533461A3 (en) | Prame derived peptides and immunogenic compositions comprising these | |
| CL2004000270A1 (es) | Compuestos derivados de pirazol, sus sales de adicion acidas,trastornos de vih y virus geneticamente relacionados. hidratos, solvatos; composiciones farmaceuticas; y su uso en el tramiento de trastornos del vih y virus geneticamente relacionados. | |
| JP2019533722A5 (enExample) | ||
| JP2018519366A5 (enExample) | ||
| JP2019513752A5 (enExample) | ||
| RU2017116973A (ru) | Способы применения и композиции нейрегулинов для предотвращения, лечения или замедления сердечной недостаточности с сохраненной фракцией выброса | |
| JP2010513327A5 (enExample) | ||
| JP2010536714A5 (enExample) | ||
| JP2014529399A5 (enExample) |